FTX-002

N/A

Report date: 2025/01/26 18:43:15

Base Information

Drug NameFTX-002
Drug Alias NameProtein-based therapy (Feldan Therapeutics)FTX-002
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFeldan Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesFeldan Therapeutics
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A